Polycystic ovary syndrome (PCOS) 
oxidase that catalyzes the oxidative deamination of peptidyl lysine and hydroxylysine to peptidyl-␣-aminoadipic-␦-semialdehyde into elastin and collagen chains. The consequent aldehydes lead to a spontaneous condensation, forming inter-and intra-chain crosslinks within these important ECM components
.
This post-translational modification of the ECM molecules appears to have a crucial role both for collagen and elastin structural properties and in triggering some still unresolved signal transduction pathways [7] . Because of its action on ECM, deficit of normal LOX expression has been described in many polygenic and monogenic disorders such as atherosclerosis, type IX Ehlers-Danlos syndrome and Menkes disease [7, 8] . Controversially, an enhanced level of LOX also seems to be involved in human pathology. Several reports have recently suggested a clear association between organ fibrosis and increased LOX activity. This has been described in several chronic human liver diseases [9] , in idiopathic and experimental lung fibrosis [10] , in experimental hepatic fibrosis [11] and adriamycin-induced kidney fibrosis in rats [12] , as well as in other pathologies resulting in fibrosis [13] [14] [15] [16] [17] .
In the ovulatory process, collagen synthesis regulated by prolyl hydroxylase and LOX activities in the ovarian follicles of rabbits is induced after follicle rupture, resulting in reconstruction of collagen fibre [18] . There is evidence from in vivo studies that LOX is expressed in rat and bovine ovarian tissue and specifically in the granulosa cell layer [19, 20] . These studies further indicate control of LOX at endocrine, paracrine and autocrine levels within the ovary and suggest coordinated regulation of ovarian ECM during follicular development [21] . Additionally, a study investigating expression of LOX in dehydroepiandrosterone (DHEA)-induced PCOS in rats showed that DHEA treatment increased LOX mRNA expression to more than three times the control levels, suggesting that increased LOX expression may be one of the causes of PCOS cystogenesis [22] . However, the presence of LOX in human ovarian tissue has not been explored, and furthermore, the mechanisms and/or the signalling molecules implicated in LOX gene regulation remain unknown.
There is mounting evidence that advanced glycation end products (AGEs) are engaged in the pathogenesis of PCOS. Increased AGE levels are present in serum of lean, normoglycaemic PCOS women and accumulate in their ovaries, possibly interfering with normal ovarian structure and function [23, 24] . AGEs are the end products of a chemical process called Maillard reaction in which the carbonyl group of carbohydrates reacts non-enzymatically with protein primary amino groups such as lysine or arginine [25] [26] [27] . Excessive AGE levels are known to stimulate the production of ECM and inhibit its degradation [28] . AGEs are capable of forming covalent cross-links with long-lived structural proteins such as collagen and elastin [28] and in doing so lead to modification of protein function by reducing their enzymatic activity, altering their biophysical properties and changing the protein interactions with other enzymes [29, 30] 
Materials and methods

General
Ovarian specimens
Ovarian tissues from six women diagnosed with PCOS, who had undergone laparoscopic ovarian wedge resection performed previously and independently of this project [37] , were partly kept frozen in liquid nitrogen and the rest were fixed in formalin and embedded in paraffin. The study of ovarian wedge resection has been approved by the local ethics committee, and written informed consent was obtained from all patients [37] . All (1) Fig.1 and Fig. 3 
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Results
Immunohistochemical detection of collagen type IV and LOX in polycystic ovaries
Previous studies have shown variations in the production and/or distribution of collagen type IV in polycystic ovaries, suggesting a possible involvement of basement membranes in the pathogenesis of PCOS [38] . In agreement with this observation, in our samples collagen type IV was detected mainly in the stroma of polycystic ovaries where both the extent (P ϭ 0.036) and the intensity (P ϭ 0.036, Fig. 1 ) of positive staining were higher compared to normal ovaries (Fig. 1A) (Fig. 1B) 
Immunohistochemical detection of AGEs in polycystic ovaries
AGE immunoreactivity in the same sections of polycystic and control ovarian tissue has been previously shown [24] . In those [24] . Fig. 2A, upper panel) . In the present study, AGE immunoreactivity was found to positively correlate with LOX staining in granulosa cells based on Kendall's t coefficient analysis (R ϭ 0.285, P ϭ 0.041) (Fig. 1B and C) . Fig. 2A, upper panel) . Fig. 2A, middle panel) . (Fig. 2A, lower panel) . (Fig. 2B) . Fig. 3Bii and Cii) . Fig. 3Bii and Cii) . Pre-incubation with the anti-NF-B p65 antibody hampered complex formation in the control tissue (Fig. 3Bii, lane 11) and drastically reduced the abundance of complex in the PCO tissue (Fig. 3Bii, lane 12) . Concurrently, pre-incubation with the anti-p-c-Jun antibody inhibited complex formation in both tissues (Fig. 3Cii,  lanes 11 and 12) .
Fig. 1 Immunodetection of collagen type IV and LOX in PCO and control samples. Immunohistochemistry was performed on sections from stromal (top panels) or follicular (bottom panel) ovarian tissue, which were stained for collagen type IV (A) and LOX (B). Increased selective staining is observed in PCO sections (magnification ϫ100). Pictures are representative of 20 sections. (C) Immunohistochemical detection of AGEs in polycystic ovaries
Positive staining is observed in the follicular cell layers (granulosa and theca layers), luteinized cells and in endothelial cells of polycystic ovaries, with stronger staining intensity observed in granulosa cells compared to normal tissue (P ϭ 0.036). AGE immunoreactivity positively correlates with LOX staining in granulosa cells (R ϭ 0.285, P ϭ 0.041). (D) Western immunoblotting of 40 g of whole-cell extract from control and PCO tissue against anti-collagen type IV and anti-LOX antibodies. Collagen type IV protein expression is increased by 3-fold and LOX protein expression by approximately 4-fold in the PCO tissue relative to control. samples, positive staining was observed in the follicular cell layers (granulosa and theca layers), luteinized cells and in endothelial cells of polycystic ovaries, with stronger staining intensity observed in granulosa cells compared to normal tissue (P ϭ 0.036) (see
Expression of collagen type IV and LOX in polycystic ovaries
In order to verify the immunostaining data and assess the protein levels of both collagen type IV and LOX in PCO tissue, we performed Western immunoblotting analysis in protein extracts derived from human ovarian tissue. The assay revealed enhanced expression of both proteins in the pathological tissue (Fig. 1D). Collagen type IV protein expression is increased by 3-fold and LOX protein expression by approximately 4-fold in the PCO tissue.
Immunohistochemical detection of phospho(p)-ERK, phospho(p)-c-Jun and NF-B p65 in polycystic ovaries
To investigate the activation of AGE signalling pathway in PCO tissue, we stained both control and PCO samples for the known AGE signalling mediator/effector molecules, p-ERK, p-c-Jun and NF-B p65. P-ERK staining was higher in the cytoplasm of granulosa cells of PCO tissue compared to normal ovaries (P ϭ 0.048) as well as in the nuclei of theca interna (P ϭ 0.048) and theca externa cells (P ϭ 0.048) compared to normal (
P-c-Jun expression was higher in the cytoplasm of granulosa cells of PCO tissue compared to normal ovaries (P ϭ 0.046) as well as in the stroma of PCO tissue. P-c-Jun staining was increased in the nuclei of stroma cells of polycystic ovaries compared to controls (P ϭ 0.048) (
NF-B p65 staining was increased in the nuclei of granulosa cells of polycystic ovaries compared to normal (P ϭ 0.036) as well as in the nuclei of theca interna (P ϭ 0.048) and theca externa cells (P ϭ 0.083) compared to normal tissue. NF-B p65 staining displayed a positive correlation with LOX staining in granulosa cell layer based on Kendall's t coefficient analysis (R
ϭ 0.2857, P ϭ 0.0412)
Protein expression of p-ERK, p-c-Jun and NF-B p65 in polycystic ovaries
In order to quantitate the protein levels of the active (i.e. phosphorylated) species p-ERK, p-c-Jun and NF-B p65, Western immunoblotting analysis was performed in whole-cell extracts isolated from healthy and PCO tissue for the presence of these molecules using appropriate antibodies. The expression levels of p-ERK, p-c-Jun and NF-B p65 were increased 2.5 to 3-fold in the PCO tissue
NF-B and AP-1 binding to LOX promoter
Co-expression of LOX and AGEs in the ovary as well as activated AGE signalling in this tissue prompted us to investigate the existence of a possible interaction between the AGEinduced transcription factors, NF-B and AP-1 and LOX promoter region. Towards this end, biotin-labelled double-stranded oligonucleotides derived from the human LOX promoter encompassing the NF-B-and AP-1-binding motifs, respectively, were used as probes in a standard EMSA employing whole-cell extracts from control and PCO tissue. A concentration-dependant DNA-protein complex was obtained for both binding reactions (Fig. 3Bi and Ci). The specificity of this complex formation was verified by binding competition analyses with 100-to 200-fold excess of the corresponding unlabelled probe (
To demonstrate the presence of NF-B p65 and p-c-Jun in the above specific DNA-protein complexes, anti-NF-B p65 and antip-c-Jun antibodies were included in the corresponding reaction mixtures prior to addition of the labelled probe (
These data provide evidence that NF-B and AP-1 could have an impact on collagen metabolism in PCO tissue by affecting LOX gene expression. [39] [40] [41] [42] . In ovaries of rat models with PCOS, induced by administration of DHEA, increased LOX mRNA expression has been implicated to be one of the causes of the cystogenesis in PCOS [21] . Intracellular AGE signalling has been shown to stimulate the production of ECM and up-regulate collagen type IV expression in various cell types such as mesangial cells [31] Although the cellular origins of the type IV collagen-rich basement membrane of the follicle are a matter of controversy [43] , there is evidence that granulosa cells have the capacity to produce and secrete many of their components [44] . Previous studies have shown that LOX mRNA expression being restricted to the granulosa cell compartment of the ovary, pointing to a local mechanism for assembly of the basement membrane ECM collagen component [19] . However, expression of collagen type IV has been demonstrated in the theca cells of human follicles [45] in the granulosa cells [24] . [61, 62] .
LOX mRNA levels in ovarian tissue
Discussion
LOX plays a critical role in the organization of ECM, stabilizing the molecules of collagen and elastin
Quantitative assays of LOX mRNA levels in PCO tissue compared to normal revealed an increase in the levels of LOX mRNA (3-fold) and protein (4-fold) , which is in symphony with data from experimental animals with androgen-induced PCOS phenotype [22] 
